efficacy of pfizer's weight-loss drug 'inferior' to others on the market, says ubs's colin bristow
Published 1 year ago • 3.9K plays • Length 3:19
Download video MP4
Download video MP3
Similar videos
-
5:26
dr. scot gottlieb on novo nodrisk's oral diabetes drug, future of weight-loss drugs
-
4:01
pfizer's weight loss pill may enter regulatory studies next year, says ceo albert bourla
-
6:29
dr. scott gottlieb on weight loss drugs side effects, eli lilly's direct-to-consumer bet
-
5:52
pharma industry remains in 'early innings' of new weight loss drug boom, says scott gottlieb
-
3:43
eli lilly's valuation is justified when you look at the growth profile, says ubs' bristow
-
5:32
these are the stocks to buy for the next 10 years
-
5:58
big pharma history - how john d rockefeller created western medicine
-
1:04:57
dave ricks, ceo of eli lilly | the all-in interview
-
6:01
what other industries could weight loss drugs disrupt?
-
5:22
eii lilly's weight-loss drug is 'much better' than others on the market, says wells fargo's bansal
-
0:55
pfizer ceo: weight loss pill may enter regulatory studies next year
-
5:05
pfizer is far behind weight loss drug race despite pill trial, says mizuho's jared holz
-
6:14
new developments in weight-loss drugs: novo nordisk, eli lilly & pfizer advance studies
-
2:10
pfizer advances development of once-daily formulation of oral weight loss pill
-
5:52
expectations for pfizer have been low, says mizuho's jared holz on weight-loss pill setback
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
5:06
eli lilly and novo can 'coexist for awhile' in the weight-loss drug space, says bmo's evan seigerman
-
3:17
bofa's geoff meacham on eli lilly on q4 results: the story has changed to diabetes and obesity
-
1:46
eli lilly releases new form of weight loss drug zepbound for half the price to boost access, supply
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
2:36
dietary supplement risks
Clip.africa.com - Privacy-policy